These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7911420)

  • 41. Receptor imaging of human diseases using radiolabeled peptides.
    Reubi JC; Lamberts SJ; Krenning EP
    J Recept Signal Transduct Res; 1995; 15(1-4):379-92. PubMed ID: 8903952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy.
    Slooter GD; Aalbers AG; Breeman WA; Hiemstra CA; Marquet RL; Krenning EP; van Eijck CH
    J Nucl Med; 2002 Dec; 43(12):1681-7. PubMed ID: 12468520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatostatin and somatostatin receptors in fish growth.
    Sheridan MA; Hagemeister AL
    Gen Comp Endocrinol; 2010 Jul; 167(3):360-5. PubMed ID: 19735661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway.
    Felley CP; O'Dorisio TM; Howe B; Coy DH; Mantey SA; Pradhan TK; Sutliff VE; Jensen RT
    Am J Physiol; 1994 May; 266(5 Pt 1):G789-98. PubMed ID: 7911277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis.
    ten Bokum AM; Lichtenauer-Kaligis EG; Melief MJ; van Koetsveld PM; Bruns C; van Hagen PM; Hofland LJ; Lamberts SW; Hazenberg MP
    J Endocrinol; 1999 Apr; 161(1):167-75. PubMed ID: 10194540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro.
    de Bruin TW; Kwekkeboom DJ; Van't Verlaat JW; Reubi JC; Krenning EP; Lamberts SW; Croughs RJ
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1310-7. PubMed ID: 1430093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.
    Reubi JC; Laissue J; Waser B; Horisberger U; Schaer JC
    Ann N Y Acad Sci; 1994 Sep; 733():122-37. PubMed ID: 7978860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors.
    Schoeffter P; Pérez J; Langenegger D; Schüpbach E; Bobirnac I; Lübbert H; Bruns C; Hoyer D
    Eur J Pharmacol; 1995 Mar; 289(1):163-73. PubMed ID: 7781707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging tumors with peptide-based radioligands.
    Behr TM; Gotthardt M; Barth A; Béhé M
    Q J Nucl Med; 2001 Jun; 45(2):189-200. PubMed ID: 11476170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial staging of lymphoma with octreotide and other receptor imaging agents.
    Ferone D; Semino C; Boschetti M; Cascini GL; Minuto F; Lastoria S
    Semin Nucl Med; 2005 Jul; 35(3):176-85. PubMed ID: 16098291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspectives of new potential therapeutic applications of somatostatin analogs.
    Pawlikowski M; Melen-Mucha G
    Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peptides as regulators of the immune system: emphasis on somatostatin.
    Krantic S
    Peptides; 2000 Dec; 21(12):1941-64. PubMed ID: 11150654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition.
    Tan CK; Podila PV; Taylor JE; Nagorney DM; Wiseman GA; Gores GJ; LaRusso NF
    Gastroenterology; 1995 Jun; 108(6):1908-16. PubMed ID: 7768398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
    Banzo J; Abós MD; Prats E; García F; Razola P
    Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
    [No Abstract]   [Full Text] [Related]  

  • 56. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease.
    Krassas GE; Dumas A; Pontikides N; Kaltsas T
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):571-80. PubMed ID: 7634496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatostatin receptors in the gastrointestinal tract in health and disease.
    Reubi JC
    Yale J Biol Med; 1992; 65(5):493-503; discussion 531-6. PubMed ID: 1340064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatostatin receptors in nasopharyngeal carcinoma.
    Loh KS; Waser B; Tan LK; Ruan RS; Stauffer E; Reubi JC
    Virchows Arch; 2002 Nov; 441(5):444-8. PubMed ID: 12447673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
    Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA
    Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.